Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

NCT02161965 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

51

Enrollment

OTHER_GOV

Sponsor class

Conditions

Permanent Atrial Fibrillation
Venous Thrombosis
Pulmonary Embolism
Anticoagulation Treatment at Least > or = to 12-month

Interventions

DRUG: Rivaroxaban
DRUG: Fluindione
DRUG: Warfarin

Sponsor

University Hospital, Angers